Literature DB >> 10149968

Tissue regeneration by use of collagen-glycosaminoglycan copolymers.

I V Yannas1.   

Abstract

Simple chemical analogs of extracellular matrices have been synthesized by graft copolymerization of a glycosaminoglycan on to type I collagen. A few of these collagen-graft-glycosaminoglycan copolymers (CG copolymers) have diverted decisively the kinetics and mechanism of skin wound healing in animals and humans away from contraction and scar synthesis, towards the direction of skin regeneration. Detailed animal studies show that CG copolymers show maximum biological activity when the average pore diameter and the degradation rate in collagenase are controlled within critical limits. When seeded with a minimum number of cells these active copolymers induce regeneration of skin, including synthesis of a new epidermis and a new dermis in the correct anatomical relationship. Certain unseeded copolymers have also induced regeneration of peripheral nerve. Another copolymer has induced regeneration of the knee meniscus. The unusual biological activity of these copolymers has led to extensive, successful clinical testing of novel medical devices for the treatment of skin loss with severely burned patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 10149968     DOI: 10.1016/0267-6605(92)90098-e

Source DB:  PubMed          Journal:  Clin Mater        ISSN: 0267-6605


  21 in total

1.  Understanding the effect of mean pore size on cell activity in collagen-glycosaminoglycan scaffolds.

Authors:  Ciara M Murphy; Fergal J O'Brien
Journal:  Cell Adh Migr       Date:  2010 Jul-Sep       Impact factor: 3.405

Review 2.  Meniscus allograft transplantation: a current concepts review.

Authors:  James H Lubowitz; Peter C M Verdonk; John B Reid; René Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-02-28       Impact factor: 4.342

Review 3.  Scaffolds and cells for tissue regeneration: different scaffold pore sizes-different cell effects.

Authors:  Ieva Bružauskaitė; Daiva Bironaitė; Edvardas Bagdonas; Eiva Bernotienė
Journal:  Cytotechnology       Date:  2015-06-20       Impact factor: 2.058

Review 4.  Novel approaches to bone grafting: porosity, bone morphogenetic proteins, stem cells, and the periosteum.

Authors:  Peter Petrochenko; Roger J Narayan
Journal:  J Long Term Eff Med Implants       Date:  2010

5.  Thermal analysis reveals differential effects of various crosslinkers on bovine annulus fibrosis.

Authors:  Keng Zhu; Paul Slusarewicz; Tom Hedman
Journal:  J Orthop Res       Date:  2011-01       Impact factor: 3.494

6.  Micro-computed tomography analysis of early stage bone healing using micro-porous titanium mesh for guided bone regeneration: preliminary experiment in a canine model.

Authors:  Yunia Dwi Rakhmatia; Yasunori Ayukawa; Yohei Jinno; Akihiro Furuhashi; Kiyoshi Koyano
Journal:  Odontology       Date:  2017-04-07       Impact factor: 2.634

7.  The use of collagen cross-linking agents to enhance dentin bond strength.

Authors:  Aiman Al-Ammar; James L Drummond; Ana Karina Bedran-Russo
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-10       Impact factor: 3.368

8.  The impact of discrete compartments of a multi-compartment collagen-GAG scaffold on overall construct biophysical properties.

Authors:  D W Weisgerber; D O Kelkhoff; S R Caliari; B A C Harley
Journal:  J Mech Behav Biomed Mater       Date:  2013-07-26

Review 9.  A Paradigm of Fibroblast Activation and Dermal Wound Contraction to Guide the Development of Therapies for Chronic Wounds and Pathologic Scars.

Authors:  Howard Levinson
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-05       Impact factor: 4.730

10.  A Novel Bone Substitute Based on Recombinant Type I Collagen for Reconstruction of Alveolar Cleft.

Authors:  Masaaki Ito; Taku Toriumi; Takahiro Hiratsuka; Hideto Imura; Yasunori Akiyama; Ichinnorov Chimedtseren; Yoshinori Arai; Kazuhiro Yamaguchi; Akihiko Azuma; Ken-Ichiro Hata; Nagato Natsume; Masaki Honda
Journal:  Materials (Basel)       Date:  2021-04-29       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.